Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7289 - 7296 of 12008 results
WEBINAR – Access, Correction, Erasure and Portability under the GDPR: How to Minimize the Burden
February 14, 2017| Blog| Viewpoint
Update: Administration’s Possible Next Steps on the Travel Ban
February 14, 2017| Alert| Viewpoint
Upcoming Event: Overview of Seed Stage Financing Structures
February 13, 2017| Blog| Viewpoint
Massachusetts Bankruptcy Court Sends a Reminder on Avoiding the Substantive Consolidation Trap
February 13, 2017| Blog| Viewpoint
Who is Watching you Watch TV? If You Have VIZIO ... Your TV Might Be Watching You
February 13, 2017| Blog| Viewpoint
Trump's Next Immigration Moves May Rock Businesses
February 13, 2017| News
New FDA Enforcement Stats Show Shifting Targets
February 13, 2017| News
Appellate Court Rejects Effort to Reinstate Travel Ban
February 10, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|